Gilead Sciences CDR (GILD.CA) Fundamental Analysis & Valuation

TSX:GILD

Current stock price

29.43 CAD
-0.34 (-1.14%)
Last:

This GILD.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. GILD.CA Profitability Analysis

1.1 Basic Checks

  • In the past year GILD was profitable.
  • In the past year GILD had a positive cash flow from operations.
  • GILD had positive earnings in each of the past 5 years.
  • Each year in the past 5 years GILD had a positive operating cash flow.
GILD.CA Yearly Net Income VS EBIT VS OCF VS FCFGILD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • The Return On Assets of GILD (14.42%) is better than 100.00% of its industry peers.
  • With an excellent Return On Equity value of 37.49%, GILD belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • GILD has a Return On Invested Capital of 19.49%. This is amongst the best in the industry. GILD outperforms 100.00% of its industry peers.
  • GILD had an Average Return On Invested Capital over the past 3 years of 17.55%. This is significantly above the industry average of 11.71%.
  • The last Return On Invested Capital (19.49%) for GILD is above the 3 year average (17.55%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROIC 19.49%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
GILD.CA Yearly ROA, ROE, ROICGILD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • The Profit Margin of GILD (28.90%) is better than 100.00% of its industry peers.
  • GILD's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 39.98%, GILD belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GILD has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 78.83%, GILD belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
  • GILD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
GILD.CA Yearly Profit, Operating, Gross MarginsGILD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

7

2. GILD.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GILD is creating value.
  • GILD has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GILD has been reduced compared to 5 years ago.
  • Compared to 1 year ago, GILD has an improved debt to assets ratio.
GILD.CA Yearly Shares OutstandingGILD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
GILD.CA Yearly Total Debt VS Total AssetsGILD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.06 indicates that GILD is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • GILD has a better Altman-Z score (2.06) than 82.61% of its industry peers.
  • GILD has a debt to FCF ratio of 2.64. This is a good value and a sign of high solvency as GILD would need 2.64 years to pay back of all of its debts.
  • GILD has a better Debt to FCF ratio (2.64) than 91.30% of its industry peers.
  • GILD has a Debt/Equity ratio of 0.97. This is a neutral value indicating GILD is somewhat dependend on debt financing.
  • GILD has a Debt to Equity ratio of 0.97. This is comparable to the rest of the industry: GILD outperforms 52.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Altman-Z 2.06
ROIC/WACC2.47
WACC7.89%
GILD.CA Yearly LT Debt VS Equity VS FCFGILD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • GILD has a Current Ratio of 1.55. This is a normal value and indicates that GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.55, GILD is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
  • A Quick Ratio of 1.40 indicates that GILD should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.40, GILD is doing good in the industry, outperforming 60.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.4
GILD.CA Yearly Current Assets VS Current LiabilitesGILD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

5

3. GILD.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.79% over the past year.
  • Measured over the past 5 years, GILD shows a small growth in Earnings Per Share. The EPS has been growing by 2.83% on average per year.
  • Looking at the last year, GILD shows a small growth in Revenue. The Revenue has grown by 2.40% in the last year.
  • Measured over the past years, GILD shows a small growth in Revenue. The Revenue has been growing by 3.58% on average per year.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%

3.2 Future

  • GILD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.10% yearly.
  • Based on estimates for the next years, GILD will show a small growth in Revenue. The Revenue will grow by 5.49% on average per year.
EPS Next Y8.46%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
EPS Next 5Y10.1%
Revenue Next Year3.46%
Revenue Next 2Y4.77%
Revenue Next 3Y4.94%
Revenue Next 5Y5.49%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GILD.CA Yearly Revenue VS EstimatesGILD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GILD.CA Yearly EPS VS EstimatesGILD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

9

4. GILD.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 2.65, the valuation of GILD can be described as very cheap.
  • GILD's Price/Earnings ratio is rather cheap when compared to the industry. GILD is cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.70. GILD is valued rather cheaply when compared to this.
  • GILD is valuated cheaply with a Price/Forward Earnings ratio of 2.45.
  • GILD's Price/Forward Earnings ratio is rather cheap when compared to the industry. GILD is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, GILD is valued rather cheaply.
Industry RankSector Rank
PE 2.65
Fwd PE 2.45
GILD.CA Price Earnings VS Forward Price EarningsGILD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • GILD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GILD is cheaper than 100.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, GILD is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.84
EV/EBITDA 2.85
GILD.CA Per share dataGILD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of GILD may justify a higher PE ratio.
PEG (NY)0.31
PEG (5Y)0.94
EPS Next 2Y9.79%
EPS Next 3Y9.45%

5

5. GILD.CA Dividend Analysis

5.1 Amount

  • GILD has a Yearly Dividend Yield of 2.26%.
  • Compared to an average industry Dividend Yield of 0.45, GILD pays a better dividend. On top of this GILD pays more dividend than 95.65% of the companies listed in the same industry.
  • GILD's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

  • The dividend of GILD has a limited annual growth rate of 3.30%.
  • GILD does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)3.3%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • GILD pays out 47.04% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP47.04%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
GILD.CA Yearly Income VS Free CF VS DividendGILD.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
GILD.CA Dividend Payout.GILD.CA Dividend Payout, showing the Payout Ratio.GILD.CA Dividend Payout.PayoutRetained Earnings

GILD.CA Fundamentals: All Metrics, Ratios and Statistics

Gilead Sciences CDR

TSX:GILD (3/13/2026, 7:00:00 PM)

29.43

-0.34 (-1.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners92.51%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap36.53B
Revenue(TTM)29.44B
Net Income(TTM)8.51B
Analysts81.05
Price Target32.47 (10.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly Dividend4.41
Dividend Growth(5Y)3.3%
DP47.04%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.2%
Min EPS beat(2)0.73%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)3.61%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)8
Avg EPS beat(12)7.27%
EPS beat(16)12
Avg EPS beat(16)9.04%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)2.29%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)8
Avg Revenue beat(12)0.99%
Revenue beat(16)12
Avg Revenue beat(16)2.6%
PT rev (1m)11.55%
PT rev (3m)N/A
EPS NQ rev (1m)-7.64%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.9%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.77%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.65
Fwd PE 2.45
P/S 0.91
P/FCF 2.84
P/OCF 2.68
P/B 1.18
P/tB N/A
EV/EBITDA 2.85
EPS(TTM)11.09
EY37.68%
EPS(NY)12.02
Fwd EY40.85%
FCF(TTM)10.36
FCFY35.2%
OCF(TTM)10.98
OCFY37.3%
SpS32.26
BVpS24.87
TBVpS-2.84
PEG (NY)0.31
PEG (5Y)0.94
Graham Number78.78
Profitability
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROCE 24.94%
ROIC 19.49%
ROICexc 25.18%
ROICexgc 81.81%
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
FCFM 32.11%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
ROICexc(3y)21.91%
ROICexc(5y)20.22%
ROICexgc(3y)88.7%
ROICexgc(5y)94.18%
ROCE(3y)22.46%
ROCE(5y)21.44%
ROICexgc growth 3Y-8.45%
ROICexgc growth 5Y-2.47%
ROICexc growth 3Y8.85%
ROICexc growth 5Y10%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Debt/EBITDA 1.52
Cap/Depr 20.4%
Cap/Sales 1.91%
Interest Coverage 11.36
Cash Conversion 68.94%
Profit Quality 111.11%
Current Ratio 1.55
Quick Ratio 1.4
Altman-Z 2.06
F-Score8
WACC7.89%
ROIC/WACC2.47
Cap/Depr(3y)20.34%
Cap/Depr(5y)24.78%
Cap/Sales(3y)1.96%
Cap/Sales(5y)2.14%
Profit Quality(3y)796.33%
Profit Quality(5y)548.85%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y8.46%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
EPS Next 5Y10.1%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.46%
Revenue Next 2Y4.77%
Revenue Next 3Y4.94%
Revenue Next 5Y5.49%
EBIT growth 1Y8.73%
EBIT growth 3Y1.14%
EBIT growth 5Y3.47%
EBIT Next Year18.57%
EBIT Next 3Y11.36%
EBIT Next 5Y10.85%
FCF growth 1Y-8.25%
FCF growth 3Y4.25%
FCF growth 5Y4.69%
OCF growth 1Y-7.48%
OCF growth 3Y3.36%
OCF growth 5Y4.17%

Gilead Sciences CDR / GILD.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Gilead Sciences CDR (GILD.CA) stock?

ChartMill assigns a fundamental rating of 7 / 10 to GILD.CA.


What is the valuation status for GILD stock?

ChartMill assigns a valuation rating of 9 / 10 to Gilead Sciences CDR (GILD.CA). This can be considered as Undervalued.


How profitable is Gilead Sciences CDR (GILD.CA) stock?

Gilead Sciences CDR (GILD.CA) has a profitability rating of 9 / 10.


What is the valuation of Gilead Sciences CDR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for Gilead Sciences CDR (GILD.CA) is 2.65 and the Price/Book (PB) ratio is 1.18.


How sustainable is the dividend of Gilead Sciences CDR (GILD.CA) stock?

The dividend rating of Gilead Sciences CDR (GILD.CA) is 5 / 10 and the dividend payout ratio is 47.04%.